Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, OH.
Department of Radiology, University of Kentucky, Lexington, KY.
Spine (Phila Pa 1976). 2023 Aug 15;48(16):1155-1165. doi: 10.1097/BRS.0000000000004703. Epub 2023 May 5.
Systematic review and meta-analysis.
To perform a systematic review and meta-analysis of previous studies on HbA1c in preoperative risk stratification in patients undergoing spinal procedures and provide an overview of the consensus recommendations.
Diabetes mellitus (DM) and hyperglycemia have been shown to be independent risk factors for increased surgical complications. Glycated Hemoglobin A1C (HbA1c), a surrogate for long term glycemic control, is an important preoperative parameter that may be optimized to reduce surgical complications and improve patient-reported outcomes. However, comprehensive systematic reviews on preoperative HbA1c and postoperative outcomes in spine surgery have been limited.
We systematically searched PubMed, EMBASE, Scopus, and Web-of-Science for English-language studies from inception through April 5 th , 2022, including references of eligible articles. The search was conducted according to PRISMA guidelines. Only studies in patients undergoing spine surgery with preoperative HbA1c values and postoperative outcomes available were included.
A total of 22 articles (18 retrospective cohort studies, 4 prospective observational studies) were identified with level of evidence III or greater. The majority of studies (n=17) found that elevated preoperative HbA1c was associated with inferior outcomes or increased risk of complications. Random-effect meta-analysis demonstrated that patients with preoperative HbA1c >8.0% had increased risk(s) of postoperative complications (RR: 1.85, 95% CI: [1.48, 2.31], P <0.01) and that patients with surgical site infection (SSI) had higher preoperative HbA1c (Mean Difference: 1.49%, 95% CI: [0.11, 2.88], P =0.03).
The findings of this study suggest that HbA1c >8.0% is associated with an increased risk of complications. HbA1c was higher by 1.49% on average among patients with SSI when compared to patients who did not experience SSI. These results suggest that elevated HbA1c is associated with less favorable outcomes following spine surgery.
IV.
系统评价和荟萃分析。
对接受脊柱手术的患者术前风险分层中糖化血红蛋白(HbA1c)的既往研究进行系统评价和荟萃分析,并提供共识建议的概述。
糖尿病(DM)和高血糖已被证明是手术并发症增加的独立危险因素。糖化血红蛋白 A1C(HbA1c)是长期血糖控制的替代指标,是一个重要的术前参数,可能通过优化来降低手术并发症并改善患者报告的结果。然而,关于脊柱手术术前 HbA1c 和术后结果的综合系统评价有限。
我们系统地检索了 PubMed、EMBASE、Scopus 和 Web-of-Science 数据库,从成立到 2022 年 4 月 5 日,以英文发表的研究,包括合格文章的参考文献。搜索遵循 PRISMA 指南。仅纳入了有术前 HbA1c 值和术后结果的接受脊柱手术的患者的研究。
共确定了 22 篇文章(18 篇回顾性队列研究,4 篇前瞻性观察性研究),证据水平为 III 级或更高。大多数研究(n=17)发现,术前 HbA1c 升高与较差的结果或并发症风险增加相关。随机效应荟萃分析表明,术前 HbA1c >8.0%的患者术后并发症风险增加(RR:1.85,95%CI:[1.48,2.31],P <0.01),且发生手术部位感染(SSI)的患者术前 HbA1c 较高(平均差异:1.49%,95%CI:[0.11,2.88],P =0.03)。
本研究的结果表明,HbA1c >8.0%与并发症风险增加相关。与未发生 SSI 的患者相比,发生 SSI 的患者的 HbA1c 平均高 1.49%。这些结果表明,HbA1c 升高与脊柱手术后的结果较差相关。
IV。